Table 1.
Patients with liver disease and patients who underwent liver transplantation
| Disease | Diagnosis | n (M/F) |
| Liver disease | Alcoholic liver cirrhosis | 152 (94/58) |
| Autoimmune hepatitis type I | 77 (27/50) | |
| Viral hepatitis B | 117 (67/50) | |
| Viral hepatitis C | 147 (82/65) | |
| Wilson’s disease | 31 (13/18) | |
| Primary biliary cirrhosis | 32 (4/28) | |
| Primary sclerosing cholangitis | 59 (40/19) | |
| Nonalcoholic steatohepatitis | 23 (10/12) | |
| Liver steatosis | 132 (77/55) | |
| Budd-Chiari syndrome | 14 (5/9) | |
| Polycystic liver | 10 (1/9) | |
| Others1 | 168 (74/94) | |
| OLTx | Alcoholic liver cirrhosis | 164 (131/33) |
| Autoimmune hepatitis type I | 33 (11/22) | |
| Viral hepatitis B | 33 (20/13) | |
| Viral hepatitis C | 79 (56/23) | |
| Wilson’s disease | 29 (12/17) | |
| Primary biliary cirrhosis | 40 (5/35) | |
| Primary sclerosing cholangitis | 64 (47/17) | |
| Cryptogenic liver cirrhosis | 28 (16/12) | |
| Budd-Chiari syndrome | 6 (2/4) | |
| Polycystic liver | 14 (3/11) | |
| Others2 | 33 (16/17) |
1
Drug-induced hepatitis, cryptogenic liver cirrhosis, hepatitis A, hepatocellular carcinoma, focal nodular hyperplasia, mild liver test abnormalities, etc.;
2
Cryptogenic liver cirrhosis, hepatocellular carcinoma, hematochromatosis, alpha-1-antitrypsin deficiency, etc. M/F: Male/female; OLTx: Patients who underwent liver transplantation.